Clinical Pharmacist Services on Admission to a Large Correctional Center.


Journal

Journal of correctional health care : the official journal of the National Commission on Correctional Health Care
ISSN: 1940-5200
Titre abrégé: J Correct Health Care
Pays: United States
ID NLM: 9503759

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 12 5 2020
pubmed: 12 5 2020
medline: 14 1 2021
Statut: ppublish

Résumé

The clinical role of pharmacists in a correctional facility has not been fully described. We report the proportion of patients assessed by a pharmacist within 48 hours of admission to a large correctional facility. Of those assessed, the frequency and type of pharmacist interventions were described. A retrospective chart review was conducted for patients admitted to the Edmonton Remand Center (ERC) from September to November 2017. From 1,500 patients, 518 (34.5%) were assessed by a pharmacist, and 511 (98.6%) of those received one or more pharmacist interventions. Interventions were most commonly health care provider interactions (89.0%) and drug therapy interventions (76.1%). ERC pharmacists assessed a sizable proportion of admitted patients, with most receiving at least one pharmacist intervention.

Identifiants

pubmed: 32390542
doi: 10.1177/1078345820921145
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-112

Auteurs

Ashwin Bhat (A)

Pharmacy Services, Alberta Health Services, Edmonton, Alberta, Canada.

Mary Gunther (M)

Pharmacy Services, Alberta Health Services, Edmonton, Alberta, Canada.

Tammy J Bungard (TJ)

Department of Medicine, Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada.

Stewart MacLennan (S)

Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.

Kim Taube (K)

Pharmacy Services, Alberta Health Services, Edmonton, Alberta, Canada.

Peter Macek (P)

Pharmacy Services, Alberta Health Services, Edmonton, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH